Medullary Thyroid Carcinoma

Pheochromocytomas in Multiple Endocrine Neoplasia Type 2

Medullary Thyroid Carcinoma

Recent results in cancer research Fortschritte der Krebsforschung Progrès dans les recherches sur le cancer, January 2015

26494388

978-3-31-922541-8, 978-3-31-922542-5

Venessa H. M. Tsang, Lyndal J. Tacon, Diana L. Learoyd, Bruce G. Robinson, Tsang, Venessa H. M., Tacon, Lyndal J., Learoyd, Diana L., Robinson, Bruce G.

Pheochromocytoma (PC) is a neuroendocrine tumor that originates from chromaffin cells of the adrenal medulla. The production of catecholamines, including epinephrine, norepinephrine and dopamine, may lead to haemodynamic instability. Over 30 % of PCs are associated with germline mutations, including re-arranged in transfection (RET) mutations seen in multiple endocrine neoplasia type 2 (MEN2) syndromes. Around 40 % of individuals with MEN2 develop PC, though it is rarely the presenting feature. Compared to sporadic PC, MEN2-associated PC is more likely to be epinephine secreting and demonstrate bilateral adrenal involvement, and is less likely to be malignant. The diagnosis of PC requires clinical suspicion and biochemical testing, followed by imaging studies. Novel nuclear medicine modalities, including FDG positron emission tomography (PET) and (68)Ga DOTATATE PET have added to the conventional techniques of (123) I-metaiodobenzylguanindine (MIBG) scintigraphy, computer tomography and magnetic resonance imaging. Treatment of PC is surgical and requires peri-operative alpha and, frequently, beta blockade. Novel surgical techniques, such as adrenal sparing surgery and a laparoscopic approach, have decreased peri-operative morbidity. Surveillance for PC is life long, due to the risk of metastatic disease.